Acurx Pharma (ACXP) Q3 2026 Earnings Call Transcript
Enrollment is underway in a recurrent C. difficile study
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
See How Centrus Energy Ranks Among Analysts' Top Metals Picks
A study of analyst recommendations at the major brokerages shows that Centrus Energy Corp (Symbol: LEU) is the #27 broker analyst pick, on average, out of the 50 stocks making up the Metals Channel…
Synopsys Takes Over #6 Spot From Take-Two Interactive Software
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Synopsys Inc (Symbol: SNPS) has taken over the #6 spot from Take-Two Interactive Software…
A $776 Car Payment Is a Warning for Ford and General Motors
Key PointsRising new vehicle prices, and the consumer payments that accompany those prices, are stretching new buyers thin.
Fermi Inc. (FRMI) Q3 2026 Earnings Call Transcript
Management details a hyperscaler prepayment and a capital-light growth model.
Why SpaceX Stock Popped After Nvidia's CEO News
Key PointsNvidia CEO Jensen Huang resigned last night, roiling the AI semiconductor industry.
Fed faces tougher inflation fight as pressure builds for more rate hikes
Data: FactSet; Chart: Courtenay Brown/Axios Inflation is no longer confined to a handful of trouble spots. Now, Federal Reserve officials are starting to question whether raising interest rates…